| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | 0.077 | 0.3 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K45681478 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.3 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |